Skip to main content
Gut logoLink to Gut
. 1999 Feb;44(2):270–273. doi: 10.1136/gut.44.2.270

Anti-inflammatory drugs and variceal bleeding: a case-control study

V De Ledinghen 1, D Heresbach 1, O Fourdan 1, P Bernard 1, M Liebaert-Bories 1, J Nousbaum 1, A Gourlaouen 1, M Becker 1, D Ribard 1, P Ingrand 1, C Silvain 1, M Beauchant 1
PMCID: PMC1727398  PMID: 9895389

Abstract

Background—Non-steroidal anti-inflammatory drugs (NSAIDs) can have severe gastrointestinal effects and cause peptic ulcers to bleed. Acute bleeding from oesophageal varices is a major complication of cirrhosis of the liver. 
Aims—To investigate the role, using a case-control study, of NSAIDs in first bleeding episodes associated with oesophageal or cardial varices in cirrhotic patients. 
Patients/Methods—A structured interview was conducted of 125cirrhotic patients with bleeding mainly related to oesophageal varices and 75 cirrhotic controls with oesophageal varices who had never bled. 
Results—Cirrhotic patients who were admitted for bleeding related to portal hypertension were more likely to have used NSAIDs during the week before the index day (31 of 125 (25%)) than the cirrhotic controls (eight of 75 (11%); odds ratio = 2.8, p = 0.016). Use of aspirin alone or combined with other NSAIDs was also more prevalent in the cases (21 of 125 (17%)) than in the controls (three of 75 (4%); odds ratio = 4.9, p = 0.007). Logistic regression analysis showed that NSAID use (p = 0.022, odds ratio = 2.9, 95% confidence interval = 1.8 to 4.7) and variceal size (p<0.001, odds ratio = 4.0, 95% confidence interval = 1.4 to 11.5) were the only variables independently associated with the risk of bleeding. 
Conclusions—Aspirin, used alone or combined with other NSAIDs, was associated with a first variceal bleeding episode in patients with cirrhosis. Given the life threatening nature of this complication, the possible benefit of this treatment should be weighed against the risk shown here. No firm conclusions could be drawn on non-aspirin NSAIDs used alone. 



Keywords: portal hypertension; non-steroidal anti-inflammatory drugs; variceal bleeding; aspirin; cirrhosis

Full Text

The Full Text of this article is available as a PDF (104.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison M. C., Howatson A. G., Torrance C. J., Lee F. D., Russell R. I. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992 Sep 10;327(11):749–754. doi: 10.1056/NEJM199209103271101. [DOI] [PubMed] [Google Scholar]
  2. Bellary S. V., Isaacs P. E., Lee F. I. Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage. Am J Gastroenterol. 1991 Aug;86(8):961–964. [PubMed] [Google Scholar]
  3. Eastwood G. L., Beck B. D., Castell D. O., Brown F. C., Fletcher J. R. Beneficial effect of indomethacin on acid-induced esophagitis in cats. Dig Dis Sci. 1981 Jul;26(7):601–608. doi: 10.1007/BF01367672. [DOI] [PubMed] [Google Scholar]
  4. Gabriel S. E., Jaakkimainen L., Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991 Nov 15;115(10):787–796. doi: 10.7326/0003-4819-115-10-787. [DOI] [PubMed] [Google Scholar]
  5. Garcia-Tsao G., Groszmann R. J., Fisher R. L., Conn H. O., Atterbury C. E., Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985 May-Jun;5(3):419–424. doi: 10.1002/hep.1840050313. [DOI] [PubMed] [Google Scholar]
  6. García Rodríguez L. A., Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994 Mar 26;343(8900):769–772. doi: 10.1016/s0140-6736(94)91843-0. [DOI] [PubMed] [Google Scholar]
  7. Heller S. R., Fellows I. W., Ogilvie A. L., Atkinson M. Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. Br Med J (Clin Res Ed) 1982 Jul 17;285(6336):167–168. doi: 10.1136/bmj.285.6336.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henry D., Dobson A., Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 1993 Oct;105(4):1078–1088. doi: 10.1016/0016-5085(93)90952-9. [DOI] [PubMed] [Google Scholar]
  9. Holt S., Rigoglioso V., Sidhu M., Irshad M., Howden C. W., Mainero M. Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding. Dig Dis Sci. 1993 Sep;38(9):1619–1623. doi: 10.1007/BF01303169. [DOI] [PubMed] [Google Scholar]
  10. Holvoet J., Terriere L., Van Hee W., Verbist L., Fierens E., Hautekeete M. L. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut. 1991 Jul;32(7):730–734. doi: 10.1136/gut.32.7.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Laine L., Peterson W. L. Bleeding peptic ulcer. N Engl J Med. 1994 Sep 15;331(11):717–727. doi: 10.1056/NEJM199409153311107. [DOI] [PubMed] [Google Scholar]
  12. Lanas A. I., Arroyo M. T., Esteva F., Cornudella R., Hirschowitz B. I., Sáinz R. Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. Gut. 1996 Nov;39(5):654–660. doi: 10.1136/gut.39.5.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lanas A., Hirschowitz B. I. Significant role of aspirin use in patients with esophagitis. J Clin Gastroenterol. 1991 Dec;13(6):622–627. doi: 10.1097/00004836-199112000-00005. [DOI] [PubMed] [Google Scholar]
  14. Langman M. J., Weil J., Wainwright P., Lawson D. H., Rawlins M. D., Logan R. F., Murphy M., Vessey M. P., Colin-Jones D. G. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994 Apr 30;343(8905):1075–1078. doi: 10.1016/s0140-6736(94)90185-6. [DOI] [PubMed] [Google Scholar]
  15. Laporte J. R., Carné X., Vidal X., Moreno V., Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding. Lancet. 1991 Jan 12;337(8733):85–89. doi: 10.1016/0140-6736(91)90744-a. [DOI] [PubMed] [Google Scholar]
  16. Lebrec D., De Fleury P., Rueff B., Nahum H., Benhamou J. P. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980 Dec;79(6):1139–1144. [PubMed] [Google Scholar]
  17. Mahmud T., Scott D. L., Bjarnason I. A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann Rheum Dis. 1996 Apr;55(4):211–213. doi: 10.1136/ard.55.4.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ordinas A., Escolar G., Cirera I., Viñas M., Cobo F., Bosch J., Terés J., Rodés J. Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology. 1996 Nov;24(5):1137–1142. doi: 10.1053/jhep.1996.v24.pm0008903388. [DOI] [PubMed] [Google Scholar]
  19. Ponce J., Froufe A., de la Morena E., Mir J., Rayón M., Pina R., Berenguer J. Morphometric study of the esophageal mucosa in cirrhotic patients with variceal bleeding. Hepatology. 1981 Nov-Dec;1(6):641–646. doi: 10.1002/hep.1840010613. [DOI] [PubMed] [Google Scholar]
  20. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  21. Ryan P., Hetzel D. J., Shearman D. J., McMichael A. J. Risk factors for ulcerative reflux oesophagitis: a case-control study. J Gastroenterol Hepatol. 1995 May-Jun;10(3):306–312. doi: 10.1111/j.1440-1746.1995.tb01098.x. [DOI] [PubMed] [Google Scholar]
  22. Semble E. L., Wu W. C., Castell D. O. Nonsteroidal antiinflammatory drugs and esophageal injury. Semin Arthritis Rheum. 1989 Oct;19(2):99–109. doi: 10.1016/0049-0172(89)90054-1. [DOI] [PubMed] [Google Scholar]
  23. Spence R. A., Sloan J. M., Johnston G. W. Histologic factors of the esophageal transection ring as clues to the pathogenesis of bleeding varices. Surg Gynecol Obstet. 1984 Sep;159(3):253–259. [PubMed] [Google Scholar]
  24. Strom B. L. Adverse reactions to over-the-counter analgesics taken for therapeutic purposes. JAMA. 1994 Dec 21;272(23):1866–1867. [PubMed] [Google Scholar]
  25. Taha A. S., Dahill S., Nakshabendi I., Lee F. D., Sturrock R. D., Russell R. I. Oesophageal histology in long term users of non-steroidal anti-inflammatory drugs. J Clin Pathol. 1994 Aug;47(8):705–708. doi: 10.1136/jcp.47.8.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wilcox C. M., Shalek K. A., Cotsonis G. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage. Arch Intern Med. 1994 Jan 10;154(1):42–46. [PubMed] [Google Scholar]
  27. Wilkins W. E., Ridley M. G., Pozniak A. L. Benign stricture of the oesophagus: role of non-steroidal anti-inflammatory drugs. Gut. 1984 May;25(5):478–480. doi: 10.1136/gut.25.5.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wolfsen H. C., Wang K. K. Etiology and course of acute bleeding esophageal ulcers. J Clin Gastroenterol. 1992 Jun;14(4):342–346. doi: 10.1097/00004836-199206000-00015. [DOI] [PubMed] [Google Scholar]
  29. Wong F., Massie D., Hsu P., Dudley F. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis. Gastroenterology. 1993 Mar;104(3):869–876. doi: 10.1016/0016-5085(93)91024-c. [DOI] [PubMed] [Google Scholar]
  30. de Lédinghen V., Mannant P. R., Foucher J., Perault M. C., Barrioz T., Ingrand P., Vandel B., Silvain C., Beauchant M. Non-steroidal anti-inflammatory drugs and variceal bleeding: a case-control study. J Hepatol. 1996 May;24(5):570–573. doi: 10.1016/s0168-8278(96)80142-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES